Xia Yu

Summit Therapeutics Inc. · Director

Xia Yu is listed in public filings as director. This Xia Yu insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Summit Therapeutics Inc. (SMMT). Investors use Xia Yu's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Summit Therapeutics Inc.SMMT$10.0M533.6k sharesBuyOct 21, 2025$18.74--